-
Almazan F, Galan C, Enjuanes L, 2004: The nucleoprotein is required for efficient coronavirus genome replication[J]. J Virol, 78, 12683-12688. doi: 10.1128/JVI.78.22.12683-12688.2004
-
Almazan F, DeDiego ML, Galan C, Escors D, Alvarez E, Ortego J, Sola I, Zuniga S, Alonso S, Moreno JL, Nogales A, Capiscol C, Enjuanes L, 2006: Construction of a severe acute respiratory syndrome coronavirus infectious cDNA clone and a replicon to study coronavirus RNA synthesis[J]. J Virol, 80, 10900-10906. doi: 10.1128/JVI.00385-06
-
Arabi YM, Alothman A, Balkhy HH, Al-Dawood A, AlJohani S, Al Harbi S, Kojan S, Al Jeraisy M, Deeb AM, Assiri AM, Al-Hameed F, AlSaedi A, Mandourah Y, Almekhlafi GA, Sherbeeni NM, Elzein FE, Memon J, Taha Y, Almotairi A, Maghrabi KA, Qushmaq I, Al Bshabshe A, Kharaba A, Shalhoub S, Jose J, Fowler RA, Hayden FG, Hussein MA, The Mtg, 2018: Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial[J]. Trials, 19, 81-. doi: 10.1186/s13063-017-2427-0
-
Arabi YM, Asiri AY, Assiri AM, Balkhy HH, Al Bshabshe A, Al Jeraisy M, Mandourah Y, Azzam MHA, Bin Eshaq AM, Al Johani S, Al Harbi S, Jokhdar HAA, Deeb AM, Memish ZA, Jose J, Ghazal S, Al Faraj S, Al Mekhlafi GA, Sherbeeni NM, Elzein FE, Al-Hameed F, Al Saedi A, Alharbi NK, Fowler RA, Hayden FG, Al-Dawood A, Abdelzaher M, Bajhmom W, AlMutairi BM, Hussein MA, Alothman A, 2020: Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory Syndrome[J]. N Engl J Med, 383, 1645-1656. doi: 10.1056/NEJMoa2015294
-
Azhar EI, El-Kafrawy SA, Farraj SA, Hassan AM, Al-Saeed MS, Hashem AM, Madani TA, 2014: Evidence for camel-to-human transmission of MERS coronavirus[J]. N Engl J Med, 370, 2499-2505. doi: 10.1056/NEJMoa1401505
-
Camus G, Xu S, Han B, Lu J, Dvory-Sobol H, Yu M, Cheng G, Miller MD, Doehle BP, Mo H, 2018: Establishment of robust HCV genotype 4d, 5a, and 6a replicon systems[J]. Virology, 514, 134-141. doi: 10.1016/j.virol.2017.11.003
-
de Wit E, van Doremalen N, Falzarano D, Munster VJ, 2016: SARS and MERS: recent insights into emerging coronaviruses[J]. Nat Rev Microbiol, 14, 523-534. doi: 10.1038/nrmicro.2016.81
-
Dudas G, Carvalho LM, Rambaut A, Bedford T, 2018: MERS-CoV spillover at the camel-human interface[J]. Elife, 7, e31257-. doi: 10.7554/eLife.31257
-
Ge F, Xiong S, Lin FS, Zhang ZP, Zhang XE, 2008: High-throughput assay using a GFP-expressing replicon for SARS-CoV drug discovery[J]. Antiviral Res, 80, 107-113. doi: 10.1016/j.antiviral.2008.05.005
-
Hertzig T, Scandella E, Schelle B, Ziebuhr J, Siddell SG, Ludewig B, Thiel V, 2004: Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA[J]. J Gen Virol, 85, 1717-1725. doi: 10.1099/vir.0.80044-0
-
Hurst KR, Koetzner CA, Masters PS, 2013: Characterization of a critical interaction between the coronavirus nucleocapsid protein and nonstructural protein 3 of the viral replicase-transcriptase complex[J]. J Virol, 87, 9159-9172. doi: 10.1128/JVI.01275-13
-
Kato F, Nio Y, Yagasaki K, Suzuki R, Hijikata M, Miura T, Miyazaki I, Tajima S, Lim CK, Saijo M, Takasaki T, Hishiki T, 2019: Identification of inhibitors of dengue viral replication using replicon cells expressing secretory luciferase[J]. Antiviral Res, 172, 104643-. doi: 10.1016/j.antiviral.2019.104643
-
Kuo L, Hurst-Hess KR, Koetzner CA, Masters PS, 2016: Analyses of Coronavirus Assembly Interactions with Interspecies Membrane and Nucleocapsid Protein Chimeras[J]. J Virol, 90, 4357-4368. doi: 10.1128/JVI.03212-15
-
Lee JY, Bae S, Myoung J, 2019: Middle East respiratory syndrome coronavirus-encoded ORF8b strongly antagonizes IFN-β promoter activation: its implication for vaccine design[J]. J Microbiol, 57, 803-811. doi: 10.1007/s12275-019-9272-7
-
Muller MA, Meyer B, Corman VM, Al-Masri M, Turkestani A, Ritz D, Sieberg A, Aldabbagh S, Bosch BJ, Lattwein E, Alhakeem RF, Assiri AM, Albarrak AM, Al-Shangiti AM, Al-Tawfiq JA, Wikramaratna P, Alrabeeah AA, Drosten C, Memish ZA, 2015: Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study[J]. Lancet Infectious Diseases, 15, 559-564. doi: 10.1016/S1473-3099(15)70090-3
-
Siu YL, Teoh KT, Lo J, Chan CM, Kien F, Escriou N, Tsao SW, Nicholls JM, Altmeyer R, Peiris JS, Bruzzone R, Nal B, 2008: The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles[J]. J Virol, 82, 11318-11330. doi: 10.1128/JVI.01052-08
-
van Boheemen S, de Graaf M, Lauber C, Bestebroer TM, Raj VS, Zaki AM, Osterhaus AD, Haagmans BL, Gorbalenya AE, Snijder EJ, Fouchier RA, 2012: Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans[J]. MBio, 3, e00473-e00512.
-
WHO (2019) Middle East respiratory syndrome coronavirus (MERS-CoV). https://www.who.int/emergencies/mers-cov/en/
-
Xie X, Zou J, Shan C, Yang Y, Kum DB, Dallmeier K, Neyts J, Shi PY, 2016: Zika Virus Replicons for Drug Discovery[J]. EBioMedicine, 12, 156-160. doi: 10.1016/j.ebiom.2016.09.013
-
Yang Y, Zhang L, Geng H, Deng Y, Huang B, Guo Y, Zhao Z, Tan W, 2013: The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists[J]. Protein Cell, 4, 951-961. doi: 10.1007/s13238-013-3096-8
-
Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA, 2012: Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia[J]. N Engl J Med, 367, 1814-1820. doi: 10.1056/NEJMoa1211721
-
Zeng LP, Gao YT, Ge XY, Zhang Q, Peng C, Yang XL, Tan B, Chen J, Chmura AA, Daszak P, Shi ZL, 2016: Bat Severe Acute Respiratory Syndrome-Like Coronavirus WIV1 Encodes an Extra Accessory Protein, ORFX, Involved in Modulation of the Host Immune Response[J]. J Virol, 90, 6573-6582. doi: 10.1128/JVI.03079-15
-
Zhang Y, Song W, Chen S, Yuan Z, Yi Z, 2021: A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2[J]. Antiviral Res, 185, 104974-. doi: 10.1016/j.antiviral.2020.104974
-
Zúñiga S, Cruz JL, Sola I, Mateos-Gómez PA, Palacio L, Enjuanes L, 2010: Coronavirus nucleocapsid protein facilitates template switching and is required for efficient transcription[J]. J Virol, 84, 2169-2175. doi: 10.1128/JVI.02011-09